A ATAI LIFE SCIENCES NV
| Market Cap | $1.35B |
| P/E Ratio | — |
| Forward P/E | -7.21 |
| Dividend Yield | — |
| Beta | 1.62 |
| 52W Range | $1.15 - $6.75 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Ruane Cunniff Ruane Cunniff & Goldfarb | 0.00% | $0 | 0 | Sold |
Insider Trading
| Insider Name of the company insider who made the trade 3 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Craig Kevin JamesChief Medical Officer | Sale | 100,000 | $3.55 | $355.00K | 20 Mar 2026 | 20 Mar 2026 |
| Feilding-Mellen Cosmo | Sale | 39,594 | $3.90 | $154.38K | 02 Jan 2026 | 06 Jan 2026 |
| Cosmo Feilding-MellenDirector | Sale | 39,594 | $3.90 | $154.38K | 02 Jan 2026 | 06 Jan 2026 |
Frequently Asked Questions
What is ATAI stock price today?
ATAI LIFE SCIENCES NV (ATAI) is currently trading at $3.73. The stock has a 52-week range of $1.15 to $6.75 and a market capitalization of $1.35B.
Is ATAI a good stock to buy in 2026?
ATAI LIFE SCIENCES NV has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +161.7%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling ATAI stock?
There have been 3 insider transactions for ATAI in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has ATAI stock performed over the past year?
ATAI LIFE SCIENCES NV (ATAI) has returned +161.7% over the past 12 months. The stock traded between $1.15 and $6.75 during this period, and is currently at $3.73.
Which hedge funds own ATAI (ATAI LIFE SCIENCES NV)?
1 tracked hedge funds currently hold ATAI in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is ATAI's market cap and valuation?
ATAI LIFE SCIENCES NV (ATAI) has a market capitalization of $1.35B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is ATAI's revenue and profitability?
ATAI LIFE SCIENCES NV reported revenue of $3.02M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.62.
What sector is ATAI in and who are its biggest institutional holders?
ATAI LIFE SCIENCES NV (ATAI) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.